McKellar, Michael R.; Frank, Matthew; Huskamp, Haiden; … - In: Forum for Health Economics & Policy 15 (2012) 2
Abstract Despite bringing breakthrough medications to market, pharmaceutical companies incurred criticism during the 1990s and early 2000s because of high prices of many drugs. We argue that the benefits of pharmaceuticals should be evaluated in a dynamic context that extends beyond the patent...